⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Class Action by Pomerantz LLP Filed Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
AARD
Investor Alert: Deadline Approaching to Join Aardvark Therapeutics, Inc. (AARD) Class Action - Contact Levi & Korsinsky
accessnewswire.com
AARD
Did You Lose Money on Aardvark Therapeutics, Inc. (AARD)? Levi & Korsinsky Urges Investors to Act Before October 13, 2026
accessnewswire.com
AARD
Did You Lose Money on Aardvark Therapeutics, Inc. (AARD)? Levi & Korsinsky Urges Investors to Act Before October 13, 2026
accessnewswire.com
AARD
Class Action Lawsuit Now Underway by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Pomerantz LLP Reports Filing of Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
October 13, 2026 Deadline: Join Class Action Lawsuit Against Aardvark Therapeutics, Inc. (AARD) – Contact Levi & Korsinsky
accessnewswire.com
AARD
October 13, 2026 Deadline Approaching: Join Class Action Against Aardvark Therapeutics, Inc. (AARD) – Contact Levi & Korsinsky
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 13, 2026 Deadline
accessnewswire.com
AARD